v3.26.1
Stockholders’ Deficit - Schedule of Stock Options Roll Forward (Details)
$ / shares in Units, $ in Thousands
 6 Months Ended 12 Months Ended
Jul. 31, 2026
USD ($)
$ / shares
shares
Jan. 31, 2026
USD ($)
$ / shares
shares
Number of Options    
Outstanding, beginning of period (in shares) | shares 8,970,353  
Granted (in shares) | shares 0  
Exercised (in shares) | shares (312,727)  
Cancelled (in shares) | shares (500)  
Outstanding, end of period (in shares) | shares 8,657,126 8,970,353
Options vested, number of options (in shares) | shares 3,656,764  
Options exercisable, number of options (in shares) | shares 3,656,764  
Weighted- Average Exercise Price    
Outstanding, beginning of period (in dollars per share) | $ / shares $ 29.20  
Granted (in dollars per share) | $ / shares 0  
Exercised (in dollars per share) | $ / shares 4.85  
Cancelled (in dollars per share) | $ / shares 7.99  
Outstanding, end of period (in dollars per share) | $ / shares 30.08 $ 29.20
Options vested, weighted average exercise price per share (in dollars per share) | $ / shares 27.46  
Options exercisable, weighted average exercise price per share (in dollars per share) | $ / shares $ 27.46  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]    
Options outstanding, weighted average remaining contractual term 7 years 3 months 18 days 7 years 7 months 6 days
Options vested, weighted average remaining contractual term 6 years 8 months 12 days  
Options exercisable, weighted average remaining contractual term 6 years 8 months 12 days  
Options outstanding, aggregate intrinsic value | $ $ 366,013 $ 239,954
Options exercised, aggregate intrinsic value | $ 19,123  
Options exercisable, aggregate intrinsic value | $ 164,195  
Options vested, aggregate intrinsic value | $ $ 164,195